US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Helix Acquisition Corp. II

9.90

0.0000

Volume:- -

Turnover:- -

Market Cap:232.74M

PE:49.28

High:9.90

Open:9.90

Low:9.90

Close:9.90

52wk High:11.59

52wk Low:8.50

Shares:23.51M

Float Shares:5.68M

Volume Ratio:1.58

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2009

EPS(LYR):0.3591

ROE:--

ROA:-0.55%

PB:1.24

PE(LYR):27.57

Loading ...

Overview Company News Filings

Helix Acquisition Corp. II Releases Proforma Financials Highlighting BridgeBio Oncology Therapeutics Merger

Helix Acquisition Corp. II Files Initial Statement of Beneficial Ownership for Director Raymond J. Kelleher

Helix Acquisition Corp. II Retains Over 60% of Trust Account Post-Redemptions, Securing $382 Million for BridgeBio Oncology Merger

Helix Acquisition Corp. Ii Retains More Than 60% of Trust Account After Redemptions in Connection With Business Combination With BridgeBio Oncology Therapeutics

THOMSON REUTERS

Helix Acquisition Corp. II Conducted Extraordinary General Meeting

Press Release: Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination

Helix Acquisition to Merge With BridgeBio Oncology Therapeutics

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HLXB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HLXB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLXB\",,,,,undefined,":{"symbol":"HLXB","market":"US","secType":"STK","nameCN":"Helix Acquisition Corp. II","latestPrice":9.9,"timestamp":1757448000000,"preClose":9.9,"halted":8,"volume":0,"delay":0,"floatShares":5679040,"shares":23509000,"eps":0.200897,"marketStatus":"Pre-Mkt","change":0,"latestTime":"09-10 08:43:52 EDT","open":9.9,"high":9.9,"low":9.9,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.200897,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757511000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"BBOT","executeDate":"2025-08-12"},"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":9.9,"volumeRatio":1.5831439546232524},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLXB\",,,,,undefined,":{"symbol":"HLXB","floatShares":5679040,"roa":"-0.55%","roe":"--","lyrEps":0.359083,"volumeRatio":1.5831439546232524,"shares":23509000,"dividePrice":0,"high":9.9,"amplitude":0,"preClose":9.9,"low":9.9,"week52Low":8.5,"pbRate":"1.24","week52High":11.59,"institutionHeld":0,"latestPrice":9.9,"eps":0.200897,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.200897,"open":9.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLXB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"HLXB","reason":null,"defaultRemindTime":1755005400000,"announcedDate":"2025-08-11","type":"delisting","dateTimestamp":1754971200000},{"market":"US","date":"2025-08-12","symbol":"HLXB","oldSymbol":"HLXB","defaultRemindTime":1755005400000,"newSymbol":"BBOT","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1754971200000},{"market":"US","date":"2025-05-15","symbol":"HLXB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"HLXB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLXB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HLXB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HLXB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HLXB","date":"2025-08-12","current":49.335764,"percent":0.99162,"low":-6230.798475,"twenty":-5915.029502,"median":-5714.611916,"eighty":33.564346,"high":51.996906,"avg":-4097.795162,"sd":2681.72792,"marketCap":232739100},"quantilePoints":[{"date":"2024-02-09","current":-4887.028687,"twenty":-4887.028687,"median":-4887.028687,"eighty":-4887.028687,"marketCap":203750000},{"date":"2024-02-16","current":-5790.439413,"twenty":-5686.648518,"median":-5111.832006,"eighty":-4979.882232,"marketCap":241415000},{"date":"2024-02-23","current":-5769.560107,"twenty":-5703.230836,"median":-5637.684447,"eighty":-5050.255445,"marketCap":240544500},{"date":"2024-03-01","current":-5692.632639,"twenty":-5742.086012,"median":-5686.648518,"eighty":-5138.221961,"marketCap":237337240},{"date":"2024-03-08","current":-5681.148446,"twenty":-5742.086012,"median":-5686.893169,"eighty":-5523.72719,"marketCap":236858441},{"date":"2024-03-15","current":-5709.117097,"twenty":-5720.106735,"median":-5686.648518,"eighty":-5628.892737,"marketCap":238024510},{"date":"2024-03-22","current":-5659.663724,"twenty":-5714.611916,"median":-5681.395723,"eighty":-5628.892737,"marketCap":235962700},{"date":"2024-03-28","current":-5666.037705,"twenty":-5714.611916,"median":-5668.345534,"eighty":-5632.189629,"marketCap":236228444},{"date":"2024-04-05","current":-5681.643001,"twenty":-5714.611916,"median":-5670.653363,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-04-12","current":-5681.643001,"twenty":-5714.611916,"median":-5681.395723,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-04-19","current":-5681.643001,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5635.48652,"marketCap":236879060},{"date":"2024-04-26","current":-5654.168905,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5632.189629,"marketCap":235733610},{"date":"2024-05-03","current":-5681.643001,"twenty":-5711.315025,"median":-5681.643001,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-05-10","current":-5681.643001,"twenty":-5699.226422,"median":-5681.643001,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-05-17","current":-5681.643001,"twenty":-5689.335748,"median":-5681.643001,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-05-24","current":-5637.684448,"twenty":-5687.13782,"median":-5681.643001,"eighty":-5632.189629,"marketCap":235046340},{"date":"2024-05-31","current":-5637.684448,"twenty":-5687.13782,"median":-5681.643001,"eighty":-5632.189629,"marketCap":235046340},{"date":"2024-06-07","current":-5785.338674,"twenty":-5687.13782,"median":-5681.148446,"eighty":-5634.387557,"marketCap":241202340},{"date":"2024-06-14","current":-5774.061211,"twenty":-5705.820205,"median":-5681.643001,"eighty":-5637.684448,"marketCap":240732160},{"date":"2024-06-21","current":-5751.506284,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5637.684448,"marketCap":239791800},{"date":"2024-06-28","current":-5774.061211,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5637.684448,"marketCap":240732160},{"date":"2024-07-05","current":-5751.506284,"twenty":-5742.086012,"median":-5681.643001,"eighty":-5637.684448,"marketCap":239791800},{"date":"2024-07-12","current":-5774.061211,"twenty":-5751.506284,"median":-5681.643001,"eighty":-5637.684448,"marketCap":240732160},{"date":"2024-07-15","current":-5751.506284,"twenty":-5751.506284,"median":-5681.643001,"eighty":-5637.684448,"marketCap":239791800},{"date":"2024-08-02","current":-5830.448527,"twenty":-5751.506284,"median":-5681.643001,"eighty":-5637.684448,"marketCap":243083060},{"date":"2024-08-09","current":-5864.280917,"twenty":-5757.145016,"median":-5681.643001,"eighty":-5637.684448,"marketCap":244493600},{"date":"2024-08-16","current":-5864.280917,"twenty":-5774.061211,"median":-5681.643001,"eighty":-5637.684448,"marketCap":244493600},{"date":"2024-08-23","current":-5867.100283,"twenty":-5774.061211,"median":-5681.643001,"eighty":-5637.684448,"marketCap":244611145},{"date":"2024-08-30","current":-5813.532332,"twenty":-5785.338674,"median":-5684.14576,"eighty":-5637.684448,"marketCap":242377790},{"date":"2024-09-06","current":-5824.809796,"twenty":-5794.145447,"median":-5687.13782,"eighty":-5637.684448,"marketCap":242847970},{"date":"2024-09-13","current":-5864.280917,"twenty":-5820.29881,"median":-5687.13782,"eighty":-5637.684448,"marketCap":244493600},{"date":"2024-09-20","current":-5892.474575,"twenty":-5836.087259,"median":-5700.874868,"eighty":-5637.684448,"marketCap":245669050},{"date":"2024-09-27","current":-5892.474575,"twenty":-5862.025425,"median":-5714.611916,"eighty":-5644.278231,"marketCap":245669050},{"date":"2024-10-04","current":-5878.377746,"twenty":-5864.280917,"median":-5714.611916,"eighty":-5654.168905,"marketCap":245081325},{"date":"2024-10-11","current":-5920.668234,"twenty":-5864.280917,"median":-5742.086012,"eighty":-5654.168905,"marketCap":246844500},{"date":"2024-10-18","current":-5841.725991,"twenty":-5864.280917,"median":-5742.086012,"eighty":-5654.168905,"marketCap":243553240},{"date":"2024-10-25","current":-5915.029502,"twenty":-5864.280917,"median":-5751.506284,"eighty":-5656.366833,"marketCap":246609410},{"date":"2024-10-31","current":-5920.668234,"twenty":-5864.280917,"median":-5751.506284,"eighty":-5659.663724,"marketCap":246844500},{"date":"2024-11-08","current":-5892.474575,"twenty":-5864.280917,"median":-5754.32565,"eighty":-5660.762688,"marketCap":245669050},{"date":"2024-11-15","current":-5934.765063,"twenty":-5866.53641,"median":-5762.783747,"eighty":-5665.334376,"marketCap":247432225},{"date":"2024-11-22","current":-5875.558381,"twenty":-5875.558381,"median":-5774.061211,"eighty":-5666.960837,"marketCap":244963780},{"date":"2024-11-29","current":-5892.474575,"twenty":-5875.558381,"median":-5774.061211,"eighty":-5670.653363,"marketCap":245669050},{"date":"2024-12-06","current":-5892.474575,"twenty":-5878.377746,"median":-5774.061211,"eighty":-5670.653363,"marketCap":245669050},{"date":"2024-12-13","current":-6005.249208,"twenty":-5892.418186,"median":-5782.519308,"eighty":-5670.653363,"marketCap":250370850},{"date":"2024-12-20","current":-6089.830183,"twenty":-5892.474575,"median":-5785.338674,"eighty":-5676.148182,"marketCap":253897200},{"date":"2024-12-27","current":-5869.919649,"twenty":-5892.474575,"median":-5796.616137,"eighty":-5680.148393,"marketCap":244728690},{"date":"2025-01-03","current":-6196.966085,"twenty":-5892.474575,"median":-5813.532332,"eighty":-5681.445179,"marketCap":258363910},{"date":"2025-01-10","current":-6163.133695,"twenty":-5892.474575,"median":-5824.809796,"eighty":-5681.643001,"marketCap":256953370},{"date":"2025-01-17","current":-5977.05555,"twenty":-5892.474575,"median":-5836.087259,"eighty":-5681.643001,"marketCap":249195400},{"date":"2025-01-24","current":-5926.306965,"twenty":-5901.496546,"median":-5836.087259,"eighty":-5681.643001,"marketCap":247079590},{"date":"2025-01-31","current":-6033.386477,"twenty":-5915.029502,"median":-5836.087259,"eighty":-5681.643001,"marketCap":251543949},{"date":"2025-02-07","current":-6089.773794,"twenty":-5920.668234,"median":-5836.143625,"eighty":-5681.643001,"marketCap":253894849},{"date":"2025-02-14","current":-6033.442867,"twenty":-5920.668234,"median":-5841.725991,"eighty":-5681.643001,"marketCap":251546300},{"date":"2025-02-21","current":-6033.442867,"twenty":-5920.668234,"median":-5858.642186,"eighty":-5681.643001,"marketCap":251546300},{"date":"2025-02-28","current":-6089.830183,"twenty":-5926.306965,"median":-5864.280917,"eighty":-5681.643001,"marketCap":253897200},{"date":"2025-03-07","current":-6084.191452,"twenty":-5940.403794,"median":-5864.280917,"eighty":-5681.643001,"marketCap":253662110},{"date":"2025-03-14","current":33.378737,"twenty":-5948.861892,"median":-5864.280917,"eighty":-5681.643001,"marketCap":253662110},{"date":"2025-03-21","current":33.193127,"twenty":-5940.403794,"median":-5864.280917,"eighty":-5681.643001,"marketCap":252251570},{"date":"2025-03-28","current":33.254997,"twenty":-5934.765063,"median":-5858.642186,"eighty":-5676.148182,"marketCap":252721750},{"date":"2025-04-04","current":33.595281,"twenty":-5934.765063,"median":-5841.725991,"eighty":-5666.037705,"marketCap":255307740},{"date":"2025-04-11","current":33.100323,"twenty":-5931.945697,"median":-5836.143625,"eighty":-5654.168905,"marketCap":251546300},{"date":"2025-04-17","current":33.378737,"twenty":-5927.434711,"median":-5836.087259,"eighty":-5650.872014,"marketCap":253662110},{"date":"2025-04-25","current":33.409672,"twenty":-5926.306965,"median":-5836.087259,"eighty":-5637.684448,"marketCap":253897200},{"date":"2025-05-02","current":33.564346,"twenty":-5926.306965,"median":-5833.267893,"eighty":-5637.684448,"marketCap":255072650},{"date":"2025-05-09","current":33.564346,"twenty":-5926.306965,"median":-5813.532332,"eighty":-5636.585484,"marketCap":255072650},{"date":"2025-05-16","current":33.564346,"twenty":-5921.79598,"median":-5799.435503,"eighty":-5632.189629,"marketCap":255072650},{"date":"2025-05-23","current":42.31221,"twenty":-5920.668234,"median":-5785.338674,"eighty":-5631.090665,"marketCap":254367380},{"date":"2025-05-30","current":42.233999,"twenty":-5920.668234,"median":-5785.338674,"eighty":-5619.002062,"marketCap":253897200},{"date":"2025-06-06","current":42.585949,"twenty":-5920.668234,"median":-5776.880576,"eighty":-5032.662142,"marketCap":256013010},{"date":"2025-06-13","current":42.351315,"twenty":-5920.668234,"median":-5774.061211,"eighty":32.988957,"marketCap":254602470},{"date":"2025-06-20","current":42.449079,"twenty":-5920.668234,"median":-5774.061211,"eighty":33.137445,"marketCap":255190195},{"date":"2025-06-27","current":41.647415,"twenty":-5920.668234,"median":-5766.171927,"eighty":33.224062,"marketCap":250370850},{"date":"2025-07-03","current":41.60831,"twenty":-5920.668234,"median":-5757.145016,"eighty":33.254997,"marketCap":250135760},{"date":"2025-07-11","current":41.697861,"twenty":-5920.668234,"median":-5751.506284,"eighty":33.316867,"marketCap":250674116},{"date":"2025-07-18","current":41.842943,"twenty":-5920.668234,"median":-5751.506284,"eighty":33.366363,"marketCap":251546300},{"date":"2025-07-25","current":41.96026,"twenty":-5920.668234,"median":-5742.086012,"eighty":33.434419,"marketCap":252251570},{"date":"2025-08-01","current":41.451887,"twenty":-5919.540488,"median":-5742.086012,"eighty":33.564346,"marketCap":249195400},{"date":"2025-08-08","current":49.834105,"twenty":-5915.029502,"median":-5714.611916,"eighty":33.564346,"marketCap":235090000},{"date":"2025-08-12","current":49.335764,"twenty":-5915.029502,"median":-5714.611916,"eighty":33.564346,"marketCap":232739100}],"updateTime":1757490705943},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HLXB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559605283","title":"Helix Acquisition Corp. II Releases Proforma Financials Highlighting BridgeBio Oncology Therapeutics Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2559605283","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559605283?lang=en_us&edition=fundamental","pubTime":"2025-08-13 18:07","pubTimestamp":1755079641,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II has issued proforma combined financial statements related to its recent merger and acquisition (M&A) transaction with BridgeBio Oncology Therapeutics, Inc. The transaction, which was finalized on August 11, 2025, involved Helix merging with BridgeBio Oncology, resulting in the formation of a combined entity now listed on the Nasdaq under the ticker symbol \"BBOT.\" The financial statements highlight that prior to the closing of this de-SPAC transaction, Helix conducted a private placement financing, raising $260.9 million. The combined company received a total of $366.8 million, accounting for the PIPE financing and unredeemed cash, while also reflecting the transaction costs incurred by Helix. This strategic move aims to bolster the company's mission to develop transformative medicines targeting genetic diseases and cancers.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL92fLmk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLXB","BBIO","BK4585","BK4505","BK4588","BK4139","BBOT"],"gpt_icon":0},{"id":"2558693984","title":"Helix Acquisition Corp. II Files Initial Statement of Beneficial Ownership for Director Raymond J. Kelleher","url":"https://stock-news.laohu8.com/highlight/detail?id=2558693984","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558693984?lang=en_us&edition=fundamental","pubTime":"2025-08-12 05:09","pubTimestamp":1754946564,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Raymond J. Kelleher as the beneficial owner, who serves as a Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helix Acquisition Corp. II published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nNDL9z10TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","HLXB"],"gpt_icon":0},{"id":"2557881371","title":"Helix Acquisition Corp. II Retains Over 60% of Trust Account Post-Redemptions, Securing $382 Million for BridgeBio Oncology Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2557881371","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557881371?lang=en_us&edition=fundamental","pubTime":"2025-08-06 19:33","pubTimestamp":1754479996,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II Retains Over 60% of Trust Account Post-Redemptions, Securing $382 Million for BridgeBio Oncology Merger. Helix Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, and BridgeBio Oncology Therapeutics have announced that they expect to raise approximately $382 million in gross proceeds from their business combination. This includes $120 million from Helix's trust account and around $261 million from a private placement  transaction. The PIPE financing was led by Cormorant Asset Management and features participation from several prominent investment groups. Helix retained over 60% of its trust account funds following redemptions by public shareholders. The companies plan to move swiftly towards closing the transaction once all conditions are met.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nNDL9xw1MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4585","LU0314104364.USD","IE00B64PRP62.GBP","LU2095319765.USD","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","BBIO","HLXB","BK4588","IE00BGHQF748.EUR","BBOT","LU2210150020.SGD"],"gpt_icon":0},{"id":"2557350379","title":"Helix Acquisition Corp. Ii Retains More Than 60% of Trust Account After Redemptions in Connection With Business Combination With BridgeBio Oncology Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2557350379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557350379?lang=en_us&edition=fundamental","pubTime":"2025-08-06 19:33","pubTimestamp":1754479980,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nTUA4YBJJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4588","HLXB","BBOT","BK4139","BBIO","BK4505"],"gpt_icon":0},{"id":"2557805334","title":"Helix Acquisition Corp. II Conducted Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2557805334","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557805334?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:46","pubTimestamp":1754340393,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II held an extraordinary general meeting on August 4, 2025. During the meeting, shareholders voted on several proposals. The Business Combination Proposal, which involved the entry into the Business Combination Agreement with TheRas, Inc., was approved. Additionally, the Stock Issuance Proposal, related to the issuance of shares to Helix and BBOT shareholders as well as PIPE Investors, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Helix Acquisition Corp. II published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 04, 2025, and is solely responsibl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL46Gp6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","HLXB","BK4139","BK4505","BBIO"],"gpt_icon":0},{"id":"2550958958","title":"Press Release: Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2550958958","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550958958?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:43","pubTimestamp":1752234180,"startTime":"0","endTime":"0","summary":"Extraordinary General Meeting of Helix Shareholders Scheduled for August 4, 2025. SOUTH SAN FRANCISCO & BOSTON, July 11, 2025  -- Helix Acquisition Corp. II  , a special purpose acquisition company  sponsored by Cormorant Asset Management, and TheRas, Inc.  , a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K<ALPHA> malignancies, today announced that the registration statement on Form S-4  , filed by Helix and BBOT, relating to the previously-announced business combination among Helix, BBOT, and the other parties thereto , has been declared effective by the U.S. Securities and Exchange Commission .The parties anticipate that the Business Combination will close in August 2025, subject to satisfaction of the conditions to the closing of the Business Combination.BridgeBio Oncology Therapeutics  is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","HLXB","LENZ","BK4139"],"gpt_icon":0},{"id":"2514320523","title":"Helix Acquisition to Merge With BridgeBio Oncology Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320523","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514320523?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:36","pubTimestamp":1740753360,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II  and TheRas, which does business as BridgeBio Oncology Therapeutics, said Friday they have agreed to merge to form biopharmaceutical company BridgeBio Oncology Therapeutics.The combined company is expected to have an implied pro forma equity value of about $949 million at closing based on a share price of $10.36 and no redemptions of Helix shares, and will be listed on Nasdaq with the ticker symbol BBOT, according to a joint statement.The transaction includes about $196 million from Helix's trust account and $260 million in private investment in public equity funding from Cormorant Asset Management, with contributions from other institutional investors, the companies said.Upon completion of the deal expected in Q3, BridgeBio Oncology expects to have access to about $550 million in cash, including $100 million in existing funds, assuming no redemptions by Helix shareholders, the companies said.Net proceeds from the deal will support BridgeBio Oncology's three ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4588","HLXB","LENZ","BBIO","BK4505","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}